Target intelligence / Profile preview

Endogenous antioxidant defenses

Molecular classification
Other
01

Overview

Endogenous antioxidant defenses refer to the complex physiological systems of enzymes and small molecules produced within the body that protect cells from oxidative damage caused by reactive species such as ROS and RNS. Major components include enzymatic antioxidants (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, peroxiredoxins, thioredoxin) and non-enzymatic antioxidants (glutathione, uric acid, melatonin, lipoic acid, bilirubin, polyamines, metal-binding proteins). These defenses are essential for maintaining cellular redox homeostasis, preventing damage to nucleic acids, proteins, and lipids, and modulating redox-sensitive signaling pathways. Dysfunction or depletion of endogenous antioxidant systems is associated with increased risk of many chronic diseases and aging[1][3][5][2][6][4]. This entry is considered "incorrect" as a canonical drug target since "Endogenous antioxidant defenses" encompasses many different molecules and processes and is not a specific target suitable for structured data.[1][5][3]

Other names
Endogenous antioxidant systemIntrinsic antioxidant defensesEndogenous antioxidant enzymes
02

Mechanism of action

Antioxidation (neutralization of free radicals); Enzymatic detoxification of ROS; Redox signaling modulation

03

Biological functions

Oxidative stress regulationMaintenance of redox balanceProtection from oxidative damageRegulation of cell signalingDNA, protein, and lipid repair
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseCancerAging-related diseasesInflammatory diseases
05

Safety considerations

Over-supplementation with exogenous antioxidants may shift antioxidants to act as prooxidantsDisruption of physiological redox signalingInterference with ROS-mediated cell signaling, which is necessary for normal cell function
06

Biomarkers

Activity levels of superoxide dismutase (SOD)Activity levels of catalaseActivity levels of glutathione peroxidaseLevels of reduced glutathione (GSH)Malondialdehyde (MDA) for oxidative damage

Beyond the preview

Go deeper on Endogenous antioxidant defenses.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous antioxidant defenses.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call